New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

Updated April 4th, 2021

New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

RET+ lung cancers are aggressive and have a poor prognosis, but new targeted drug selpercatinib (Retevmo) benefits more than 90% of patients who have this type of cancer.

NOW
PLAYING
4 Major Cancer Treatment Advances Happened This Week. Here's What You Missed.
NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
NOW
PLAYING
New Hope For Early Stage Non-Small Cell Lung Cancer Patients
NOW
PLAYING
Cancer Patients Should Still Wear Masks & Distance Says Leading Expert - Even in Wake of Major New CDC Guidelines
NOW
PLAYING
'Very Painful' Says Oscar-Winning Actress Laura Dern of Losing Her Grandfather to Lung Cancer When She Was 6
NOW
PLAYING
Internet Cancer Claim Debunked: Apricot Seeds Are Not Effective at Preventing or Treating Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.